Your browser doesn't support javascript.
loading
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
Gullo, Giuseppe; J Eustace, Alex; Canonici, Alexandra; M Collins, Denis; Kennedy, Michael J; Grogan, Liam; Breathhnach, Oscar; McCaffrey, John; Keane, Maccon; Martin, Michael J; Gupta, Rajnish; Leonard, Gregory; O'Connor, Miriam; Calvert, Paula M; Donnellan, Paul; Walshe, Janice; McDermott, Enda; Scott, Kathleen; Hernando, Andres; Parker, Imelda; W Murray, David; C O'Farrell, Alice; Maratha, Ashwini; Dicker, Patrick; Rafferty, Mairin; Murphy, Verena; O'Donovan, Norma; M Gallagher, William; Ky, Bonnie; Tryfonopoulos, Dimitrios; Moulton, Brian; T Byrne, Annette; Crown, John.
Affiliation
  • Gullo G; Cancer Trials Ireland (formerly All-Ireland Clinical Oncology Research Group), Dublin Ireland.
  • J Eustace A; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Canonici A; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • M Collins D; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Kennedy MJ; Department of Medical Oncology, St James Hospital, Dublin, Ireland.
  • Grogan L; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • Breathhnach O; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
  • McCaffrey J; Department of Medical Oncology, Mater Hospital, Dublin, Ireland.
  • Keane M; Department of Medical Oncology, University Hospital Galway, Galway, Ireland.
  • Martin MJ; Department of Medical Oncology, Sligo University Hospital, Sligo, Ireland.
  • Gupta R; Department of Medical Oncology, University Hospital Limerick, Limerick, Ireland.
  • Leonard G; Department of Medical Oncology, University Hospital Galway, Galway, Ireland.
  • O'Connor M; Department of Medical Oncology, University Hospital Waterford, Waterford, Ireland.
  • Calvert PM; Department of Medical Oncology, University Hospital Waterford, Waterford, Ireland.
  • Donnellan P; Department of Medical Oncology, University Hospital Galway, Galway, Ireland.
  • Walshe J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • McDermott E; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Scott K; Cancer Trials Ireland (formerly All Ireland Co-operative Oncology Research Group), DCU Alpha, Dublin, Ireland.
  • Hernando A; Cancer Trials Ireland (formerly All Ireland Co-operative Oncology Research Group), DCU Alpha, Dublin, Ireland.
  • Parker I; Cancer Trials Ireland (formerly All Ireland Co-operative Oncology Research Group), DCU Alpha, Dublin, Ireland.
  • W Murray D; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • C O'Farrell A; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Maratha A; Oncomark Ltd, University College Dublin, Dublin, Ireland.
  • Dicker P; Department of Epidemiology and Public Health Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Rafferty M; Oncomark Ltd, University College Dublin, Dublin, Ireland.
  • Murphy V; Cancer Trials Ireland (formerly All Ireland Co-operative Oncology Research Group), DCU Alpha, Dublin, Ireland.
  • O'Donovan N; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • M Gallagher W; Oncomark Ltd, University College Dublin, Dublin, Ireland.
  • Ky B; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Tryfonopoulos D; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Moulton B; Clinical Oncology Development Europe, Dublin, Ireland.
  • T Byrne A; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
Ther Adv Med Oncol ; 11: 1758835919864236, 2019.
Article in En | MEDLINE | ID: mdl-31384312
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Ther Adv Med Oncol Year: 2019 Type: Article